Explore

Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline

Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline

Kailera Therapeutics Follows Eli Lilly's Lead with Record-Breaking IPO and Obesity Drug Pipeline

CVS brings back coverage for Lilly's obesity drug Zepbound

CVS brings back coverage for Lilly's obesity drug Zepbound

May 28 (Reuters) - CVS Health said on Thursday it will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option for insurance coverage.

Kailera Therapeutics Sets Record with $625 Million IPO, Targets Obesity Market

Kailera Therapeutics Sets Record with $625 Million IPO, Targets Obesity Market

Kailera Therapeutics Sets Record with $625 Million IPO, Targets Obesity Market

Novo Nordisk and Eli Lilly CEOs Agree to Lower Drug Prices Amid Pressure from President Trump

Novo Nordisk and Eli Lilly CEOs Agree to Lower Drug Prices Amid Pressure from President Trump

Novo Nordisk and Eli Lilly CEOs Agree to Lower Drug Prices Amid Pressure from President Trump

US stocks inch to more records after oil prices drop

US stocks inch to more records after oil prices drop

U.S. stocks inched to more records after oil prices fell back to where they were in mid-April

Qualcomm makes eye-catching move with TikTok parent deal

Qualcomm makes eye-catching move with TikTok parent deal

The chip company widely known for supplying the cellular modem inside your iPhone just did something investors have been waiting years to see. On May 26, Qualcomm (QCOM) rocketed to an all-time intraday high of $258 before closing at a record $248.82, after reports that the company landed an AI ...

Louis Navellier says oil price drop hides bigger opportunity

Louis Navellier says oil price drop hides bigger opportunity

According to the Iranian Revolutionary Guards Corps (IRGC), the possibility of a return to war with the U.S. was “low,” which sent crude oil prices plunging. Nonetheless, I am adding more energy companiessince their forecasted sales and earnings remain strong. Some of the energy stocks in our ...

US space stocks rise on SpaceX IPO hype

US space stocks rise on SpaceX IPO hype

May 27 (Reuters) - Shares of U.S. space companies continued to climb on Wednesday, extending their recent rally as investors bet that rocket company SpaceX's mammoth market listing could force Wall Street to fundamentally rethink how it values the space economy.

Analyst warns Inspire Medical has a problem lasting into 2028

Analyst warns Inspire Medical has a problem lasting into 2028

Inspire Medical has spent years building a compelling sleep apnea device story, but Bank of America says the stock now faces a reimbursement problem that could take longer to resolve than investors want to hear. BofA Securities downgraded Inspire Medical (INSP) to Underperform from Neutral and ...

Merck Declares Third-Quarter 2026 Dividend, Benefiting Shareholders

Merck Declares Third-Quarter 2026 Dividend, Benefiting Shareholders

Merck Declares Third-Quarter 2026 Dividend, Benefiting Shareholders

Here’s where the next market upside comes from

Here’s where the next market upside comes from

Transcript: Caroline WoodsJoining me now, Ross Gerber, CEO of Gerber Kawasaki. Ross, great to have you back. Thanks so much for being here. Yeah. Ross GerberGreat to be back. Thanks for having me. Caroline WoodsSo we're kicking off this holiday shortened week with the S&P and Nasdaq both ...

Abercrombie & Fitch beats quarterly profit estimates on steady US demand

Abercrombie & Fitch beats quarterly profit estimates on steady US demand

May 27 (Reuters) - Abercrombie & Fitch beat first-quarter profit estimates, helped by steady domestic demand on Wednesday, but flagged some weakness in its Europe, the Middle East and Africa segment due to the ongoing U.S.-Israeli war with Iran.